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The mammalian target of rapamycin (mTOR) regulates cell growth in response to various intracellular and extracellular signals. It
assembles into two multiprotein complexes: the rapamycin-sensitive mTOR complex 1 (mTORC1) and the rapamycin-insensitive
mTORC2. In this study, we inactivated mTORC1 in mice by deleting the gene encoding raptor in the progenitors of the developing CNS.
Mice are born but never feed and die within a few hours. The brains deficient for raptor show amicrocephaly starting at E17.5 that is the
consequence of a reduced cell number and cell size. Changes in cell cycle length during late cortical development and increased cell death
both contribute to the reduction in cell number. Neurospheres derived from raptor-deficient brains are smaller, and differentiation of
neural progenitors into glia but not into neurons is inhibited. The differentiation defect is paralleled by decreased Stat3 signaling, which
is a target ofmTORC1andhasbeen implicated ingliogenesis. Together, our results show thatpostnatal survival, overall braingrowth, and
specific aspects of brain development critically depend onmTORC1 function.
Introduction
In eukaryotes, cell growth is regulated by the target of rapamycin
(TOR) pathway (Wullschleger et al., 2006; Laplante and Sabatini,
2012). Themammalian orthologmTOR (mTOR) assembles into
two distinct multiprotein complexes mTORC1 and mTORC2
(Jacinto et al., 2004; Sarbassov et al., 2004). Function ofmTORC1
requires raptor (gene abbreviated as rptor) and is inhibited by the
immunosuppressant rapamycin (Wullschleger et al., 2006;
Laplante and Sabatini, 2012). mTORC1 controls metabolism,
protein translation, ribosome biogenesis, autophagy, and tran-
scription. However, the function of mTORC1 in the developing
brain has so far not been analyzed because constitutive mTOR
and raptor-deficient embryos die shortly after implantation re-
sulting from proliferation defects (Gangloff et al., 2004;
Murakami et al., 2004; Guertin et al., 2006).
The role of mTOR in the brain has mainly been studied
using cultured cells. A few studies addressed differentiation of
neural stem cells and came to the seemingly conflicting con-
clusions that mTORC1 is either crucial for commitment into
the neuronal (Han et al., 2008) or into the glial lineage (Rajan
et al., 2003; Wang et al., 2008). Different conditions may ex-
plain these alterations, thus posing the question to which ex-
tent the chosen conditions reflect the physiological situation.
In cultured neurons, mTOR is important for polarization,
dendrite development, and axonal growth and guidance
(Swiech et al., 2008). In particular, the complexity of the den-
dritic tree is reduced upon addition of rapamycin (Jaworski et
al., 2005; Kumar et al., 2005), and local translation in growth
cones, which is important for axon guidance, is rapamycin-
sensitive (Campbell and Holt, 2001; Verma et al., 2005; Park et
al., 2008). Other studies have shown that axon specification
and elongation are mTORC1-dependent (Li et al., 2008). In
summary, in vitro data have resulted in a variety of potential
functions of mTORC1.
The role of mTOR in brain development has only been ana-
lyzed in studies of the flat-top mutant (Hentges et al., 1999)
caused by a mutation in Mtor that results in a splicing defect
(Hentges et al., 2001). Mutant embryos lack a telencephalon and
die at midgestation. Interestingly, this effect is phenocopied by
prolonged rapamycin application (Hentges et al., 2001). How-
ever, interpretation of these results is difficult because embryos
with a germline deletion ofMtor diemuch earlier (Gangloff et al.,
2004; Murakami et al., 2004). The generation of floxed alleles for
rptor (Bentzinger et al., 2008; Polak et al., 2008) now allowed us to
study the specific role of mTORC1 in the developing brain. We
find that raptor-deficient brains are uniformly smaller because of
decreased cell size and reduced cell number. Moreover, we show
that differentiation of glia is impaired with little effect on neuro-
nal differentiation.
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Materials andMethods
Generation of rptor knock-out mice in the devel-
oping brain. rptor floxedmicewere generated as
described previously (Bentzinger et al., 2008).
They were crossed with mice that express Cre
under the control of the CNS-specific nestin
promoter and enhancer (Zimmerman et al.,
1994; Tronche et al., 1999; Graus-Porta et al.,
2001). Recombination of the floxed rptor al-
leles induced a frame shift and precocious stop
of translation (see Fig. 1A). Genotyping was
performed on tail or brain lysates using prim-
ers shown in Figure 1A: P1, 5-ATG GTAGCA
GGC ACA CTC TTC ATG; P2, 5-GCT AAA
CAT TCA GTC CCT AAT C; P3, 5-CAG ATT
CAAGCA TGT CCT AAGC; Cre-forward, 5-
TGT GGC TGA TGA TCC GAA TA; Cre-
backward, 5-GCT TGC ATG ATC TCC GGT
AT. Mice that were heterozygous or homozy-
gous for the floxed rptor allele and were nega-
tive for Cre were used as control.Mice of either
sex were used in all the experiments.
Antibodies. Rabbit polyclonal antibodies are
as follows: mTOR, S6 ribosomal protein, P-S6
ribosomal protein (Ser235/236), P-mTOR
(Ser2448), P-mTOR (2481), Akt, P-Stat3
(Ser727), and cleaved Caspase 3 from Cell Sig-
nalingTechnology; brain lipid-binding protein
and Map2 fromMillipore Bioscience Research
Reagents; GAD65/67 and neurofilament from
Sigma; Ki67 from Novocastra or NeoMarkers;
and Tbr2 and Tbr1 from Abcam. Rabbit
monoclonal antibodies are as follows: raptor,
rictor, P-Akt (Ser473), P-Stat3 (Tyr705), and
-actin from Cell Signaling Technology.
Mouse monoclonal antibodies are as follows:
Stat3 from Cell Signaling Technology, GFAP
from Millipore Bioscience Research Reagents,
-tubulin III (also calledTuj1) fromSigma, and Satb2 fromAbcam.Goat
polyclonal antibodies to Sox2 were from Santa Cruz Biotechnology. Rat
monoclonal antibodies are as follows: Ctip2 fromAbcam and BrdU from
AbD Serotec. EdU detection was performed using the Click-iT imaging
Kit from Invitrogen. Sox5 antibodies raised in guinea pig were a kind gift
from Prof. M. Wegner (University of Erlangen).
Brain lysates for Western blots. RAbKO and control brains were
dissected at E19.5 or P0 and lysed in the presence of protease and
phosphatase inhibitors. Western blots were conducted using standard
procedures.
Brain sections, histochemistry and immunohistochemistry. For immu-
nohistochemistry, the heads of the embryos were fixed in 4% PFA over-
night and then cryoprotected in 30% sucrose. Brains were embedded in
OCT reagent and frozen on dry ice. For fresh frozen sections (size com-
parison, cresyl violet), heads were directly frozen in OCT on dry ice. The
10- or 12-m-thick sections were prepared with a cryostat. Fresh frozen
sections were postfixed for 20 min with 4% PFA. For paraffin sections,
brains were fixed at least 2 d in 4% PFA and paraffin-embedded using a
Shandon Pathcenter Tissue Processor. The 4-m-thick sections, cut on a
microtome, were deparaffinized and directly subjected to cresyl violet
staining. For immunohistochemistry, an antigen retrieval protocol was
applied by boiling the sections for 20 min in 0.05% Tween in 10 mM
sodium citrate buffer, pH 6.0. Immunostainings were performed using
standard procedures. For BrdU stainings, brain sections were incubated
in 2 M HCl for 7 min at 37°C and then incubated for 10 min in borate
buffer (0.1 M, pH 8.5) before immunostaining. EdU detection was done
according to the manufacturer’s instructions (Click-iT; Invitrogen).
Quantifications. For all experiments, at least three mice per genotype
were examined. For BrdU pulse-chase experiments, BrdU (50 mg/kg)
was administered to a pregnant mouse by a single intraperitoneal injec-
tion and the brains of the embryos were harvested 3, 12, or 24 h later.
Quantification was done by determining the number of BrdU-positive
cells that were localized in all or in specific layers of the cortex above a
particular length of the ventricular zone. Thus, the normalized numbers
given in the figures represent cells in a specific column of the developing
cortex. In contrast to the counting of BrdU-positive cells per total cell
number, this paradigm minimizes the introduction of artifacts because
of the size difference between the cells in controls and RAbKO mice.
Similar quantification was applied for PH3 or Caspase 3-positive cells.
Borders between cortical regionsR1, R2, andR3were defined in stainings
for BrdU, Sox2, and Tbr2 as described in Figure 4A. All quantifications
were carried out in anatomically matched regions. The total number of
cells was determined by counting the number of Hoechst-positive nuclei
in at least 3 sections per animal in a defined area that spanned from the
ventricle to the pial surface. The percentage of cells stained with a layer-
specificmarker was determined by counting the number of positive cells/
total number ofDAPI-positive cells in the respective layer. For analysis of
the cell cycle length, pregnant dams were injected first with EdU and
BrdU 1.5 h apart and killed 30min later. Analysis of 4 sections per animal
Figure 1. Rptor knock-out in the CNS causes perinatal death. A, Schematic representation of the wild-type (rptorwt) and the
targeted rptor allele before (rptor floxed) and after (rptor ko) recombination. Positions of PCR primers P1, P2, and P3 used in B are
indicated. B, PCR analysis of genomic DNA isolated from brains or the tails of newborn control (rptorfl/fl; nestin-Cre) and RAbKO
(rptorfl/fl;nestin-Cre)mice. Tissue-specific LoxP recombinationusingprimers P1 andP3 results in anampliconof 204bp for the
recombined allele and no product from nonrecombined allele. PCR using primers within the rictor allele served as control. C,
Western blot analysis for the indicated proteins using brain lysates of E19.5 control and RAbKOmice. The presence of some raptor
protein is probably the result of meninges and blood vessels, which both do not express Cre (Graus-Porta et al., 2001). D, Photo-
graphs of newborn control and RAbKO mice (top) and body weight of E19.5 mice (bottom). Error bar indicates mean SD. N is
indicated in the bars. Black bars represent control; gray bars, heterozygous (rptorfl/; nestin-Cre); open bars, RAbKOmice.
Table 1. Quantification of Western blot bands fromwhole brain lysate of E19.5
control and RAbKOmicea
Protein % of control, mean % of control, SD p N
raptor 22 4 2.4E-5 3
P-S6 30 12 1.6E-4 4
GFAP 48 22 0.013 4
Stat3 69 10 1.1E-4 4
P-Stat3-727 49 19 0.026 4
P-Stat3-705 41 6 4.1E-4 4
aThe values are normalized to the intensity of the bands observed in control mice.
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of 5 control and 5 RAbKOwas done as described previously (Martynoga
et al., 2005). The total number of proliferating cells was determined on
adjacent sections using antibodies to Ki67 and costaining with DAPI was
used to assure that all cells at E16.5 were Ki67-positive. The paired t test
was used for statistical analysis. The amount of DNA in tissue homoge-
nates wasmeasured using themethod described previously (Labarca and
Paigen, 1980).
Neurospheres. Neurospheres were prepared from P0 telencephali as de-
scribed previously (Giachino et al., 2009). To determine the capacity of sec-
ondary neurosphere formation and growth, cells were plated at a clonal
density of 3000 cells/ml (Sirko et al., 2007). Six representative images were
taken for each well of a 6-well plate to determine neurosphere number and
diameter. For differentiation, neurosphereswere split after 5–6 d and plated
onto coverslips coated with 15 g/ml poly-L-ornithine and 40 g/ml
laminin (150,000 cells/cm2). The dispersed cultures were differentiated in
neurosphere medium lacking FGF2, EGF, and heparin and fixed after 5 d
with 4% PFA (Giachino et al., 2009).
Hippocampal cultures.Hippocampi were dissected from E16.5 mice in
HBSS (Sigma) and incubated for 10 min at 37°C in HBSS containing
0.05% trypsin and 0.02% EDTA. Hippocampi were washed twice with
HBSS, triturated in plating medium (DMEM, 0.2 mg/ml L-glutamine,
1% penicillin/streptomycin, and 10% FCS), and plated at a density of
100,000 cells/cm2 on glass coverslips coatedwith 10g/ml poly-D-lysine.
After 3 h, the medium was replaced by growth medium (Neurobasal
medium; Invitrogen), 0.2 mg/ml L-glutamine, 1% penicillin/streptomy-
cin, and 2% B27 (Invitrogen). After 4 d, cells were cotransfected with a
plasmid expressing GFP from the synapsin promoter and either a Cre- or
a control plasmid, which both contained the CMV promoter. Cells were
fixed after 14 d in culture and imaged by confocal microscopy.
Results
mTORC1 controls embryonic brain size
and is required for postnatal survival
To address the role of mTORC1 in brain
development, we conditionally deleted
rptor (gene encoding raptor) in neural
progenitors using rptor floxed mice
(Bentzinger et al., 2008) and the well-
described nestin-Cremice (Tronche et al.,
1999; Graus-Porta et al., 2001). In those
rptorfl/fl; nestin-Cre (RAbKO) mice (Fig.
1,A), the floxed exon 6 in rptor was suc-
cessfully deleted in brain but not in tails as
verified using genomic DNA (Fig. 1B).
Consequently, the level of raptor was very
low in brain lysates from RAbKO mice
(Fig. 1C). The low levels of raptor remain-
ing in the brain are most likely derived
from meninges and blood vessels, which
are not targeted by nestin-Cre. Phosphor-
ylation ofmTORat serine 2448, indicative
of mTORC1 activity (Copp et al., 2009),
and of the mTORC1 target S6 was
strongly decreased in the brains of
RAbKO mice (see Fig. 1C; Table 1 for
quantification). In contrast, abrogation of
mTORC1 seemed not to affect the func-
tion of mTORC2 as the protein level of
rictor and phosphorylation of mTOR at
themTORC2 site serine 2481 (Copp et al.,
2009) and of Akt/PKB at serine 473 (Sar-
bassov et al., 2005) was not abrogated
(Fig. 1C, right). To the contrary, phos-
phorylation at both sites was rather in-
creased in RAbKO mice, consistent with
previous results from mice in which rptor
was conditionally deleted in other tissues
(Bentzinger et al., 2008; Polak et al., 2008; Shende et al., 2011).
These data are strong evidence that mTORC1 activity was elimi-
nated and that mTORC2 activity was not reduced. RAbKOmice
were born at the expected Mendelian ratio (52.3% rptorfl/;
nestin-Cre and rptorfl/fl;nestin-Cre, 25.2% rptorfl/;nestin-Cre
and 22.4% rptorfl/fl;nestin-Cre) and their body weight was nor-
mal (Fig. 1D). However, RAbKOmice became cyanotic and died
within a few hours after birth (data not shown). Their stomachs
never contained milk, and their breathing was irregular (gasp-
ing), suggesting that the mice died of respiratory failure. Inner-
vation and the positioning of the postsynaptic acetylcholine
receptors at the neuromuscular junctions of RAbKO mice were
indistinguishable from controlmice (data not shown), indicating
that the respiratory difficulties might be based on the malfunc-
tioning of higher brain centers involved in respiratory control.
The brains of RAbKO mice at E19.5 appeared smaller and
their weight was approximately only half comparedwith controls
(Fig. 2A), even though the body weight was unchanged (Fig. 1D).
The difference in brain size could be caused by a decrease in cell
number or cell size, both processes that have been reported to be
influenced by mTOR (Wullschleger et al., 2006; Laplante and
Sabatini, 2012). The total amount of DNA per brain was 30%
lower in RAbKO brains compared with controls, indicating that
the number of cells was reduced (Fig. 2B, top). However, the
relative amount of DNA per gram wet weight was increased in
Figure 2. Nestin-Cre-mediated deletion of rptor causes microcephaly. A, The brain from E19.5 RAbKO mice is considerably
smaller (top) and weighs less (bottom). B, Relative DNA amount per brain (top) and relative DNA amount per gram wet weight
(bottom). C, Cresyl violet-stained brain sections of E19.5 control and RAbKO mice at different levels in the rostrocaudal axis. D,
Cresyl violet-stained sections at E15.5 (top) and E17.5 (bottom). The brain of RAbKO mice is smaller at E17.5. E, Quantification of
cortical cell number as measured by Hoechst staining. A, B, Error bars indicate mean SD. E, Error bar indicates mean SEM. N
is indicated in the bars. ***p 0.001 (two-tailed t test). ns, Not significant ( p 0.05). Scale bars: A, 2 mm; C, D, 1 mm.
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RAbKOmice to120% compared with controls, indicating that
cell density was increased (Fig. 2B, bottom). DNA amount was
also increased inRAbKOmicewhennormalized to the amount of
protein (control: 100 8.4%,N 5mice; RAbKO: 142 20.7%,
N  3 mice; data represent mean  SD). These results indicate
that the brain of the RAbKO mice contains fewer and smaller
cells. Despite the difference in size, the overall structure of the
brain in RAbKO mice was normal at birth (Fig. 2C). The differ-
ence in brain size was detectable at E17.5 (Fig. 2D, bottom) but
not at E15.5 (Fig. 2D, top). Although there was a trend in E17.5
RAbKOmice for an increased cell density compared with con-
trol mice, this difference did not reach significance (Fig. 2E),
indicating that the smaller size of RAbKO brains at this devel-
opmental period was mainly the result of changes in cell num-
ber. Together, these data indicate that the microcephaly of
RAbKO mice at birth is the result of a decrease in cell number
and cell size. The size difference becomes apparent between
E15.5 and E17.5 and increases progressively until birth.
Raptor deficiency increases apoptosis and affects cell
cycle duration
To address the mechanism involved in the reduced cell num-
ber in RAbKO mice, the presence of apoptotic cells was as-
sessed by staining brain sections with antibodies to cleaved
Caspase 3. Only a few apoptotic cells were found in E15.5 and
E17.5 RAbKO mice (Fig. 3A,B). However, at E19.5, the num-
ber of apoptotic cells among the -tubulin III (Tuj1)-positive
neurons was 8 times higher in RAbKO mice than in control
mice (Fig. 3A,B). Staining with the neuronal marker Satb2
underlined that the vast majority of the caspase 3-positive
nuclei were neurons (Fig. 3C). Apoptotic cells were not unique
to cortical regions but could also be found at E19.5 in other
brain regions, such as the hippocampus (see Fig. 7C) or the
thalamus (data not shown). This suggests that cell death of
neurons contributes to the reduced cell number in the brain of
RAbKO mice at late developmental stages but does not con-
tribute to the size reduction at E17.5.
In search for amechanism responsible for the size difference at
the early stages, we assessed cell cycle kinetics and cell differenti-
ation. As mTORC1 has been implicated in controlling G2/M
phase transition during the cell cycle (Ramirez-Valle et al., 2010),
we analyzed proliferation in embryonic RAbKO mice by BrdU
labeling in utero. Radial glial cells in the ventricular zone of the
developing cortex display phase-related interkinetic nuclear mi-
gration during cell cycle progression (Gotz and Huttner, 2005).
DNA replication takes place in the basal region, whereas mitosis
occurs in the apical region of the ventricular zone. To determine
nuclear position, the developing cortex was divided into three
regions R1 to R3, based on Sox2 and Tbr2 staining. R1 covered
the apical VZ, R2 the basal VZ and the subventricular zone, and
R3 the intermediate zone and the cortical plate (Fig. 4A). E15.5
RAbKO embryos labeled with BrdU 3 h before death did not
show differences in the distribution of BrdU-labeled cells in
the developing cortex compared with controls (Fig. 4B,C).
When RAbKO mice were pulsed with BrdU at E15 and ana-
lyzed 12 h later, a significantly larger proportion of the BrdU-
labeled cells was detected in R1 at the expense of labeled cells
in R2 (Fig. 4D,E). After one pulse of BrdU at E14.5 and anal-
ysis 24 h later, approximately one-fourth of the BrdU-positive
nuclei in control mice were located in R1, whereas in RAbKO
mice, only very few BrdU-positive cells were found in R1 (Fig.
4F,G). In contrast, significantly more BrdU-positive cells
were present in R2 in the RAbKO mutants (Fig. 4F,G). This
nuclear position phenotype was also observed when BrdU was
injected at E16.5 and mice were analyzed at E17.5 (Fig. 4H ).
Moreover, the total number of BrdU-positive cells in a cortical
column of a given length was reduced in RAbKOmice at E17.5
but was not changed at E15.5 and E19.5 (Fig. 4I ). Thus, the
labeling of cells in S-phase by one pulse of BrdU at E16.5
results in fewer BrdU-positive cells along the entire cortical
column 24 h later but not at E15.5 or E19.5.
Figure 3. Loss of raptor leads to increased cell death during late brain development. A,
Examination of apoptosis by staining for cleaved Caspase 3, -tubulin III (Tuj1), and DAPI.
White arrows indicate apoptotic nuclei; yellow arrows indicate blood vessels. B, Quantification
of the number of caspase 3-positive cells per ventricular length in the cortex. The number of
apoptotic cells was set to 1 in control mice. C, Staining for cleaved Caspase 3 and Satb2. Apo-
ptotic cells are positive for the neuronal marker Satb2 (inset). Data are mean SD; N3
animals per genotype. *p  0.05 (two-tailed t test). Scale bars: A, C, 50 m; C insets,
25m.
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Figure 4. Depletion of raptor alters localization and number of proliferating precursor cells. A, Regions used for counting proliferating cells (BrdU-positive; red) are indicated as R1–R3 and are
defined by staining E15.5 cortical sections from controlmicewith antibodies to Tbr2 (green) and Sox2 (blue). Region R1 is defined by the exclusive presence of Sox2-positive and Tbr2-negative cells.
Region R2 contains all Tbr2-positive cells (which are also Sox2-positive). Region R3 is defined by the absence of both Sox2- and Tbr2-positive cells.B,D, F,H, Staining for BrdU (green inB,D; red in
F,H ) andDAPI (blue) at indicated time points. Immunostaining and quantification of BrdU-positive nuclei:B, C, 3 h after BrdU injection;D, E, 12 hours after BrdU injection; (Figure legend continues.)
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Loss of raptor affects neurosphere size
Neurosphere formation and maintenance are a surrogate assay
for neural stem cells (Reynolds and Weiss, 1996). Thus, we iso-
lated and cultured spherogenic neural stem/progenitor cells from
the telencephalon of P0 mice. The number of secondary neuro-
spheres generated from RAbKO and control animals was similar
(control, 10.9  3.04; RAbKO, 12.7  5.29; N 15; p  0.05),
whereas the size of RAbKO-derived neurospheres was strongly
reduced (Fig. 4 J,K). Compared with control cultures, the size
distribution in neurospheres from RAbKO mice was shifted to-
ward smaller diameters (p  1.384 	 1012; Wilcoxon two-
sample test). Thus, spherogenic stem cells seemed not to be
affected by loss of raptor, but the proliferative capacity of cells
within the neurospheres was decreased. Interestingly, a similar
proliferation defect was reported for embryonic stem cells defi-
cient for raptor or mTOR (Gangloff et al., 2004; Murakami et al.,
2004; Guertin et al., 2006).
Cell cycle exit and proliferation are reduced in raptor-
deficient neural progenitor cells
The changes in temporal–spatial distribution of progenitor cells
and the reduced number of BrdU-positive cells at E17.5 after a
24 h pulse indicated potential defects in specific periods of the cell
cycle. To test whether loss of raptor affected cell cycle exit of
progenitors, BrdU was injected into pregnant mice at day 14.5,
16.5, or 18.5 of gestation and cell cycle exit of the progenitors cells
of the embryos was examined by costaining for BrdU and Ki67
24 h after injection (Fig. 5A,B). The proportion of BrdU-positive
progenitors that exited the cell cycle (i.e., became Ki67-negative)
was not affected at E15.5 but was reduced by50% in E17.5 and
E19.5 RAbKO cortices (Fig. 5A,B). Hence, precursor cells in the
cortex of RAbKO mice in late embryonic development may re-
main longer in the cell cycle. To address this directly, cell cycle
length of control and mutant progenitor cells was tested at E16.5
by EdU/BrdU double-labeling experiments (Martynoga et al.,
2005). Cortical progenitors of RAbKO embryos showed a signif-
icant increase in length of the S-phase (Ts) and of the entire cell
cycle (Tc) compared with control (Fig. 5C). Further, there were
significantly fewer Sox2-positive apical progenitor cells (Fig.
5D,F) and a slightly, although not significantly, lower number of
Tbr2-positive basal progenitor cells (Fig. 5E,F) in E17.5 mutant
embryos. In addition, the number of PH3-positive apical progen-
itor cells (marker for cells in M-phase) that lined the ventricular
surface was lower in the mutant at E17.5 (Fig. 5G,H), but not at
E15.5 (Fig. 5H). Thus, all these data point to changes in cell cycle
characteristics upon loss of raptor in cortical progenitors.
As loss of cell polarity or detachment from the apical mem-
brane after mitosis could also result in proliferation defects
(Loulier et al., 2009), we also examined the structure of radial glial
cells in the cortex of RAbKO embryos. Like in control embryos,
radial glia in the ventricular zone of RAbKO mutants showed a
continuous and apical staining for the adhesion complex protein
-catenin (Fig. 5I). Thus, a disturbed polarity of radial glia can-
not explain the observed changes in progenitor proliferation and
differentiation in the cortex of RAbKObrains. In summary, these
data suggest that changes in cell cycle characteristics are the main
contributor to the change in brain size in RAbKO mice at E17.5.
Lengthening of the cell cycle is likely to reduce expansion of the
progenitor pool. In addition, the delay in cell cycle exit points to
potential defects in the differentiation process of mutant progen-
itor cells at later stages of development, when gliogenesis starts in
the mouse cortex.
Effect of raptor deficiency on cortical layering
Cortical precursor proliferation, differentiation, and migration
of neurons are intimately linked (Gotz and Huttner, 2005;
Baranek et al., 2012). Therefore, we examined the production of
differentiated cells in the cortical plate from E12.5 and E14.5
progenitors by BrdU pulse-chase experiments. When progeni-
tors were labeled at E12.5, no differences in BrdU-labeled prog-
eny in the cortical plate at E19.5 were observed and BrdU-labeled
cells were distributed throughout the cortical layers in both ge-
notypes (Fig. 6A). However, when labeled at E14.5, cortical
progenitor-derived cells showed a different cellular distribution
in RAbKO mice compared with controls at E19.5. Whereas in
control mice most BrdU-positive cells populated the upper cor-
tical plate (Fig. 6B), the labeled cells in RAbKO mice remained
concentrated in the ventricular zone/subventricular zone/inter-
mediate zone and fewer cells born at E14.5 reached the cortical
plate (Fig. 6B). As a consequence, the ratio between BrdU-
positive cells in the cortical plate and in the ventricular zone/
subventricular zone/intermediate zone was significantly reduced
in RAbKOmice (Fig. 6C). Despite these initial changes, the over-
all organization within the mutant cortex seemed normal at
E19.5 (Fig. 6D). To detect potentially misguided or misspecified
neurons, the distribution of layer-specific markers was assessed
by immunohistochemistry at E19.5 (Fig. 6E). The expression pat-
tern of the examined markers, including Satb2 (for layers 2–4),
Sox5 (for subplate and layers 5 and 6), Tbr1 (for layer 6), and
Ctip2 (for layer 5) was comparable between control and mutant,
and no obvious layering defects were detected (Fig. 6E). How-
ever, in RAbKO cortices, the respective layers were narrower
compared with controls, and the cells appeared more densely
packed (Fig. 6E). Thus, these findings suggest that loss of raptor
might affect the timing of the differentiation/migration pro-
cess of neurons (Fig. 6B,C). However, their specification and
correct positioning within the cortical layers appear to be un-
affected (Fig. 6E).
We also observed that Map2 staining (a dendritic marker)
was weak in the RAbKO mice compared with controls, indic-
ative of a reduction of neuropil in the cortical plate of raptor-
deficient mice (Fig. 6F ). To test whether the low Map2 signal
and the higher cell density in RAbKO cortex were the conse-
quence of a reduced dendritic complexity, we also examined
neurite outgrowth in raptor-deficient neurons in vitro. We
deleted rptor from E16.5 primary hippocampal neurons of
floxed mice after 4 d in vitro by transfection with a Cre-
expression vector. Transfected neurons were visualized by
cotransfection with a GFP-expressing vector (Fig. 6G). Sholl
analysis 10 d after transfection showed a significant decrease in
the complexity of the neurites compared with control-
transfected neurons (Fig. 6G,H ). These results are also in
agreement with previous work using rapamycin or RNAi
4
(Figure legend continued.) F,G, 24 h after BrdU injection. There is a shift in the localization of
proliferating nuclei with progression through the cell cycle. H, Injection of BrdU at E16.5 and
analysis at E17.5. *RAbKO mice have only few BrdU-positive cells in R1. I, Quantification of
BrdU-positive cells per ventricular length in the entire cortical column. J, Micrographs of sec-
ondary neurospheres derived from E19.5 brains. There is a pronounced difference in size. K,
Distribution of the diameters of secondary neurospheres. Size distribution of RAbKO neuro-
spheres is shifted to the left. Inset, Box plot of the median size of the neurospheres. Data are
from 100 control and 91mutant neurospheres. C, E, G, I, Data are mean SD. N 3mice per
genotype. Not significant: p 0.05. *p 0.05 (two-tailed t test). **p 0.01 (two-tailed t
test). Scale bars, 100m. Black bars represent control; open bars, RAbKOmice. VZ, Ventricular
zone; SVZ, subventricular zone; IZ, intermediate zone; CP, cortical plate.
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against mTOR (Jaworski et al., 2005; Kumar et al., 2005).
Thus, the decreased Map2 staining in cortical sections of
RAbKOmice could be the result of a reduction in the neuronal
complexity.
Glial differentiation is impaired in raptor-deficient brains
mTORC1 is important for neural stem/progenitor cell differen-
tiation into neurons and glia (Rajan et al., 2003; Han et al., 2008;
Wang et al., 2008). Thus, we analyzed the expression of neuronal
Figure5. Lossof raptor causesaberrant cell cycleexit andaffects cell cycle length.A, Stainingofbrain sections forBrdU(green)andKi67 (red)at indicated timepoints.B, QuantificationofBrdU/Ki67as
percentage of all BrdU cells (cell cycle exit index). At E17.5, fewer cells leave the cell cycle in RAbKOmice.C, Cell cycle length analysis at E16.5. S-phase and total cell cycle length are increased in RAbKOmice.
Staining of E17.5 cortical sectionswith antibodies to Sox2 (D) or Tbr2 (E). F, Quantification of the number of Sox 2 and Tbr 2 cells per total cell number.G, Analysis ofmitosis at E17.5 by staining for PH3.H,
QuantificationofmitoticnucleiatE15.5andE17.5. I,Stainingfor-cateninintheventricularzoneofcorticalsectionsfromE15.5andE17.5controlandRAbKOmice.B,F,H,Errorbars indicatemeanSD.C,Error
bar indicatesmean SEM.N 3mice per genotype.N 5 control and 5RAbKOmice. *p 0.05 (two-tailed t test). **p 0.01 (two-tailed t test). Scale bars:A,D,G, 100m; C, I, 20m.
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Figure 6. RAbKOmice show changes in the localization of late-generated neurons without affecting overall cortical layering. A, B, BrdU (red) and DAPI (blue) staining in E19.5 cortical sections
of mice that were injected with BrdU at E12.5 (A) or E14.5 (B). Fewer BrdU-positive cells reach the CP when labeled at E14.5. C, Quantification of the distribution of BrdU-labeled cells from
E14.5-injected mice. D, E19.5 cortical sections stained with cresyl violet. MZ, Marginal zone; CP, cortical plate; SP, subplate; IZ, intermediate zone; SVZ, subventricular zone; VZ, ventricular zone. E,
E19.5 cortical sections stainedwith antibodies to Satb2 (red) and Sox5 (green), Tbr1 (red), and Ctip2 (green). The percentage of cells positive for indicatedmarkers was determined by counting the
number of positive cells/total number of cells (DAPI-positive). Data aremean SEM;N 3mice. F, E19.5 cortical sections stainedwith antibodies toMap2 (green) and Hoechst (blue).G, Confocal
picture of culturedhippocampal neurons isolated from rptorfl/flmice thatwere transfectedwith control plasmid (control) or a Cre-expressing construct (Cre) at 4DIVandanalyzedat 14DIV. Cellswere
cotransfectedwith aGFP-expression plasmid.H, Sholl analysis of Cre-expressing and control neurons. C,N 5mice per genotype.H,N 5 control and 4RAbKOmice. *p 0.05 (two-tailed t test).
C, Data are mean SD. H, Data are confidence intervals. Scale bars: A, B, D–F, 100m; G, 50m.
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and glial proteins in the brains of E19.5 control and RAbKOmice
byWestern blot analysis.We did not detect significant changes in
the expression of the neuron-specific isoform -tubulin III or
GAD65/67, a marker for a subpopulation of inhibitory interneu-
rons (Zhu et al., 1999), or brain lipid-binding protein, a radial
glia marker reflecting the number of neuronal precursors
(Hartfuss et al., 2001) (Fig. 7A). In contrast, the astrocyticmarker
GFAP was strongly reduced in RAbKO brain lysates (Fig. 7A;
Table 1). In newborn mice, when GFAP cells start to populate
the brain (Sancho-Tello et al., 1995; Shu et al., 2003), GFAP im-
munostaining in RAbKO brains was weaker compared with con-
trols in the granule cell layer of the dentate gyrus and in the
midline glial structures: the indusium griseum glia, the midline
zipper glia, and the glial wedge (Fig. 7B). Although apoptosis was
increased in the hippocampus of RAbKOmice at E19.5, the cells
positive for Caspase 3 were not GFAP-positive (Fig. 7C). In sum-
mary, these results suggest that mTORC1 is important for the
generation of glial cells.
mTOR signaling has been linked to glial differentiation via its
ability to phosphorylate Stat3 (Yokogami et al., 2000; Rajan et al.,
2003), which regulates astrocyte development (Johe et al., 1996;
Bonni et al., 1997). Phosphorylation of Stat3 was indeed de-
creased in brain lysates of newborn RAbKO compared with con-
trol mice (Fig. 7D; Table 1). We also found a concomitant,
although less pronounced, loss of Stat3 protein, which might be
the result of instability of the nonphosphorylated Stat3 or the loss
of Stat3-expressing cells in the brain lysate. This result suggests
that failure of mTORC1-mediated activa-
tion of Stat3 may be the cause for the de-
crease in GFAP-positive cells.
To address whether the reduction in
GFAP in RAbKO mice was the result of a
reduced ability of RAbKO progenitors to
differentiate into the astroglial lineage,
differentiation was examined in dissociated
neurosphere cultures from RAbKO and
control mice. Whereas the number of
-tubulin III (Tuj1)-positive neurons was
not changed, the number of GFAP-positive
cells was much lower in 5-day-old cultures
fromRAbKOmice (Fig. 8A,B). In addition,
Western blot analysis confirmed that levels
of GFAP, but not of -tubulin III, were
lower in RAbKO-derived cell cultures and
those changes correlated with a low level of
Stat3 phosphorylation (Fig. 8C). To exam-
ine whether the changes in glial differentia-
tion were the result of inherent differences
in the stem cell pool of RAbKO mice, we
ablated rptor acutely from neural stem cells
by culturing cells from heterozygously or
homozygously floxed rptor mice followed
by infection with a Cre-expressing ade-
novirus. The acute removal of raptor
also resulted in fewer GFAP-positive
cells (Fig. 8D,E) and a reduction in
GFAP (Fig. 8F ). In addition, an increase
in the number of -tubulin III-positive
immature neurons was observed (Fig.
8D,E). In conclusion, these results indi-
cate that mTORC1 is important for the
proper differentiation of neural progen-
itor cells into the glial lineage.
Discussion
Here we addressed the role of raptor in brain development by
conditional inactivation of rptor in nestin-expressing progenitor
cellsE10.5 (Graus-Porta et al., 2001). Consistent with the con-
cept that mTORC1 controls organismal size, as shown in other
species (Oldham et al., 2000; Long et al., 2002), RAbKO mice
show microcephaly. Moreover, RAbKO mice die shortly after
birth with signs of cyanosis. In contrast, rapamycin treatment of
developing embryos results in aberrant development of the tel-
encephalon and death of the embryos already after midgestation
(Hentges et al., 2001), suggesting that rapamycin-treated em-
bryos may die because of mTORC1 inhibition in non-CNS cells
and/or to loss of activity of both mTOR complexes.
Raptor regulates progenitor cell proliferation in the
telencephalon and affects survival
Deletion of rptor in neural progenitors caused changes in cell size
and cell number, which together resulted in a reduced brain size
that became discernible fromE17.5 onwards. It is well established
that cell cycle progression and cell growth are linked because cells
need to increase their size in the G phase to assure that cell size is
maintained after mitosis (Fingar and Blenis, 2004). We here pro-
vide direct evidence that deletion of rptor affects cell division in
neural progenitors of the developing cortex. At E16.5, cell cycle
length in theRAbKOmicewas1.5 times longer than in controls
and the number of progenitor cells in the ventricular zone that
Figure7. Astrocytic differentiation is impaired inRAbKObrains in vivo.A,Westernblot analysis of E19.5 brain lysates probed for
indicated markers of neural development. B, Top, Cresyl violet stainings of brain sections from E19.5 mice. Red boxes represent
regions shown below: sections of dentate gyrus and midline glial structure regions stained with antibody to GFAP (red) and DAPI
(blue). IGG, Indusium griseum glia; MZG, midline zipper glia; GW, glial wedge. C, Analysis of apoptotic cells in E19.5 hippocampus
of RAbKO mice stained for GFAP and Caspase 3. Apoptotic cells are not GFAP-positive. The white frame represents the magnified
inset. D, Western blot analysis of E19.5 brain lysates probed for indicated proteins. Scale bars: B, C, 200m.
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were in M-phase was lower at E17.5.
These data were also corroborated by the
strong size difference between secondary
neurospheres isolated from RAbKO and
controlmice. In conclusion, our data pro-
vide strong evidence that loss of raptor af-
fects cell proliferation in the developing
brain, consistent with the role of
mTORC1 in cell cycle progression (Fingar
and Blenis, 2004). Moreover, recent evi-
dence indicates that cell cycle regulationby
mTORC1 involves phosphorylation of
mTOR and raptor (Ramirez-Valle et al.,
2010; Ekim et al., 2011) and that cell prolif-
eration depends on mTORC1-mediated
phosphorylation of 4E-BP proteins (Dowling
et al., 2010).
Our work also provides evidence that
mTORC1promotes survival of cells at late
stages of embryonic development as we
observed substantial apoptosis at E19.5.
These apoptotic events are likely to also
contribute to themicrocephaly of RAbKO
mice at birth. The apoptotic cells were
positive for Satb2 but not for GFAP, indi-
cating that this process affectsmostly neu-
ronal cells and not glia. However, we do
not know whether prevention of apopto-
sis by mTORC1 is a cell autonomous
function or a consequence of a failure of
neurons to connect to their targets as cul-
tured neurons that lack raptor showed
some deficits in neurite outgrowth.
mTORC1 can be activated by Akt3/
PKB. Like RAbKO mice, mice deficient for Akt3/PKB have
small brains and fewer cells (Easton et al., 2005; Tschopp et al.,
2005), indicating that at least some of those effects of Akt3/PKB
go throughmTORC1. In addition, S6K, which is one of the main
targets of mTORC1, has been shown to affect cell size when ab-
lated in vivo (Shima et al., 1998;Montagne et al., 1999). Thus, the
lack of S6K phosphorylation may account for the difference in
cell size observed in E19.5 RAbKO mice.
mTORC1 is involved in gliogenesis
Evidence from previous reports led to the hypothesis that
mTORC1 has an important role for neural stem/progenitor cell
differentiation into neurons and glia (Rajan et al., 2003; Han et
al., 2008; Wang et al., 2008). Our work now provides substantial
in vivo evidence that loss of raptor mainly affects gliogenesis.
Cortical progenitor cells in the mouse brain are programmed to
sequentially produce cohorts of neurons and glial cells during
embryonic development. Gliogenesis starts atE17.5 in the cor-
tex and is triggered by intrinsic signals. In addition, extrinsic
feedback signaling fromneurons in the cortical plate is needed for
correct cell-fate specification (Seuntjens et al., 2009). The impact
of rptor deletion on proliferation of neural precursors was only
detected after E15.5. These developmental stages correlate with
the beginning of gliogenesis (Franco and Muller, 2013), suggest-
ing that mTORC1 may rather affect gliogenesis than neurogen-
esis. In agreement with this notion, there was no striking
difference in the positioning of layer-specific neurons at E19.5.
Importantly, RAbKO mice showed a strong decrease in the
amount of GFAP but not of any neuronal markers at E19.5, and
dissociated cells derived from E19.5 neurospheres showed a sub-
stantial reduction in glial, but not neuronal, differentiation in
vitro. Finally, in newborn mice, when GFAP cells start to pop-
ulate the brain (Sancho-Tello et al., 1995; Shu et al., 2003), GFAP
immunostaining in RAbKO brains was weaker compared with
controls. Together, our results provide strong evidence that
mTORC1 signaling is important for gliogenesis during late cor-
tical development but has rather subtle effects on neurogenesis at
earlier time points of corticogenesis.
The effect of rptor deletion on gliogenesis correlated with a
strong effect on the Jak-Stat pathway, which controls astrocytic
differentiation (Johe et al., 1996; Bonni et al., 1997), and where
mTORC1 has been implicated in this Stat3-dependent function
(Rajan et al., 2003;Wang et al., 2008). Phosphorylation of Stat3 at
Ser727 is rapamycin-sensitive, and phosphorylation of Stat3 at
Tyr705 and Ser727 is essential formaximal activation (Wen et al.,
1995; Yokogami et al., 2000). Stat3 phosphorylation was strongly
reduced in the brains of RAbKOmice, and levels of Stat3 protein
were lower, suggesting that phosphorylation of Stat3 might be
important for the stabilization of the protein. Alternatively, the
preponderance of neuronal cells could prevent activation of the
positive autoregulatory loop of Jak-Stat signaling important for
gliogenesis (He et al., 2005). Interestingly, deletion of the
mTORC1 inhibitorTsc2, amodel for the genetic disease tuberous
sclerosis in humans, increased Stat3 phosphorylation and GFAP
expression (Onda et al., 2002).
The effect of mTORC1 on glial differentiation is also compat-
ible with the observation that a brain-specific knock-out for the
upstream activator Rheb1 (using the same nestin-Cre driver that
Figure 8. Raptor regulates astrocytic differentiation in vitro. A, Cells from dissociated neurospheres after 5 d of differentiation.
Cells were stainedwith antibodies against-tubulin III (Tuj1; red), GFAP (green), and DAPI (blue).B, Relative number of neurons
(left) and astrocytes (right) derived from dissociated neurospheres. C, Western blot analysis of lysates from dissociated neuro-
sphere cultures grown under the same conditions as in A probed with antibodies against the proteins indicated. D–F, Analysis of
differentiation in E19.5 rptorfl/ and rptorfl/fl neurospheres transduced with Cre-expressing adenoviruses. D, Micrographs of
neurosphere-derived cells after differentiation. After 5 d, cultures were stained with Tuj1 antibody (red), anti-GFAP antibody
(green), and DAPI (blue). E, Quantification of the fraction of neurons (left) and astrocytes (right) in percentage of control. F,
Western blot analysis of lysates from cultures grown under the same conditions as in D probed for the indicated marker proteins.
Sample number in E is 4 mice per genotype. Error bars indicate mean SD from three independent experiments. *p 0.05
(two-tailed t test). **p 0.01 (two-tailed t test). ns, Not significant ( p 0.05). Scale bars: A, D, 100m.
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we used to delete rptor) also shows deficits in the glial lineage
(Zou et al., 2011). Interestingly, though, those mice did not die
perinatally but survived for 5–6 weeks, and their brains were not
smaller at birth (Zou et al., 2011). Hence, deletion of rptor causes
a significantly more severe phenotype than deletion of Rheb1,
suggesting the existence of either functional redundancy in the
GTPases that activatemTORC1 during brain development or the
presence of alternative pathways that can activate mTORC1 in
neural progenitors in the absence of Rheb1.
In conclusion, our data show that mTORC1 is crucial for
normal brain growth and postnatal survival. Several aspects of
brain development are affected by deletion of rptor and thus loss
of mTORC1 function, which may together be responsible for the
death of the newborn mice. Regulation of cell size and division,
which are both affected in RAbKO mice, are processes that are
well known to be associated with mTORC1 signaling. Our data
also strongly indicate that Stat3 is an important downstream tar-
get of mTORC1 that is required for normal differentiation of
precursor cells intoGFAP-positive glia. In summary, themultiple
phenotypes of RAbKO mice described here show that mTORC1
has a central role in the integration of the inputs from several
signaling pathways.
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